Appointment of an Additional Director in the Capacity of an Independent Director with effect form May 8, 2026
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Artemis Medicare Services reported strong FY26 results with standalone revenue of Rs 1,060.5 crore, up 16% from Rs 913.3 crore in FY25. Net profit grew 24% to Rs 103.4 crore from Rs 83.5 crore. EPS stood at Rs 6.55 versus Rs 5.42. The board declared a final dividend of Rs 0.45 per share (45%) for FY26, subject to shareholder approval. Mr. Tapan Mitra was appointed as Additional Director (Independent) for 3 years from May 8, 2026. Additionally, Dr. Girdhar J. Gyani's appointment as Independent Director from August 1, 2026 was approved for shareholder consideration. Statutory auditors T R Chadha & Co LLP were reappointed for a second 5-year term.
The strong financial performance and dividend declaration are positive for shareholders. The addition of two independent directors strengthens board governance and independence, which is a reassuring signal for investors.